Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-12 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.150 | -0.0600 | ||||
REV | 500.000K | 27.000K | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
BBI | Brickell Biotech | 0.84 | 0.02 | 2.46% | 56.4M |
You can purchase shares of Brickell Biotech (NASDAQ: BBI) through any online brokerage.
Other companies in Brickell Biotech’s space includes: Biocept (NASDAQ:BIOC), Monopar Therapeutics (NASDAQ:MNPR) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
The latest price target for Brickell Biotech (NASDAQ: BBI) was reported by Lake Street on 2020-08-28. The analyst firm set a price target for 6.00 expecting BBI to rise to within 12 months (a possible 612.42% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Brickell Biotech (NASDAQ: BBI) is $0.8422 last updated Wed Apr 21 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Brickell Biotech.
There is no upcoming split for Brickell Biotech.